Physician

Vamsi Krishna Gullapalli, MD, PHD

According to 2025 Medicare claims, Vamsi Gullapalli, MD, PHD (NPI: 1649477787) practices ophthalmology in the St. Cloud, MN market, with the plurality of this provider's patient population coming from Stearns, MN. This provider's primary affiliated billing organization is CENTRAL MINNESOTA RETINA CONSULTANTS, PLLC (NPI: 1902134877; TIN: 500010471) and primary practice location at 56377-4531. Gullapalli is affiliated with the Rochester Regional Health ACO, Inc. (ACO ID: A3476), participating under the MSSP model.

Gullapalli's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 741 traditional Medicare patients, billed 28,813 HCPCS/CPT codes, and received $1,419,931 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 431 prescription claims across 152 beneficiaries totaling $15,750 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $1,136,691 to $1,419,931. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $35,106 and ending at $15,750. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.9M$3.8M2015 Medicare payment: $1,136,691 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,175,978 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,231,581 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,577,499 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,755,393 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $962,495 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $582,790 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $433,315 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $414,716 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,419,931 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156548,317$1,136,691
20166329,692$1,175,978
20176239,384$1,231,581
20186648,318$1,577,499
20191,25617,770$3,755,393
20209434,692$962,495
20214833,140$582,790
20223564,168$433,315
20234117,091$414,716
202474128,813$1,419,931

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$49K$97K2015 Drug cost: $35,106 (USD; Tot_Drug_Cst)2016 Drug cost: $40,777 (USD; Tot_Drug_Cst)2017 Drug cost: $41,318 (USD; Tot_Drug_Cst)2018 Drug cost: $48,755 (USD; Tot_Drug_Cst)2019 Drug cost: $53,042 (USD; Tot_Drug_Cst)2020 Drug cost: $39,905 (USD; Tot_Drug_Cst)2021 Drug cost: $97,042 (USD; Tot_Drug_Cst)2022 Drug cost: $47,982 (USD; Tot_Drug_Cst)2023 Drug cost: $25,331 (USD; Tot_Drug_Cst)2024 Drug cost: $15,750 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015204595$35,106
2016254905$40,777
20173021,302$41,318
20183561,623$48,755
20193021,345$53,042
2020266841$39,905
2021198767$97,042
2022167555$47,982
2023143461$25,331
2024152431$15,750

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye443772$106
92014Established patient complete exam of visual system241261$102
J9035Injection, bevacizumab, 10 mg135237$54
92134Imaging of retina7101,136$30
J2777Injection, faricimab-svoa, 0.1 mg15923,760$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate832,190$2,806
Brimonidine TartrateBrimonidine Tartrate582,774$2,628
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat825,532$1,437
DifluprednateDifluprednate12751$1,173
Atropine SulfateAtropine Sulfate331,103$1,004

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Vamsi Krishna Gullapalli, MD, PHD?

Tedicare shows public-source Medicare data for Vamsi Krishna Gullapalli, MD, PHD (NPI 1649477787), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vamsi Krishna Gullapalli, MD, PHD have ACO affiliation data?

Vamsi Krishna Gullapalli, MD, PHD is shown with ACO affiliation data for Rochester Regional Health ACO, Inc. (MSSP, ACO ID A3476).

What billing organization is linked to Vamsi Krishna Gullapalli, MD, PHD?

Vamsi Krishna Gullapalli, MD, PHD is linked to CENTRAL MINNESOTA RETINA CONSULTANTS, PLLC (billing NPI 1902134877) in the available physician profile data.

Does Vamsi Krishna Gullapalli, MD, PHD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.